National Research Corp
NASDAQ:NRC

Watchlist Manager
National Research Corp Logo
National Research Corp
NASDAQ:NRC
Watchlist
Price: 18 USD 2.04% Market Closed
Market Cap: 407.9m USD
Section:
 

Relative Value

The Relative Value of one NRC stock under the Base Case scenario is 23.44 USD. Compared to the current market price of 18 USD, National Research Corp is Undervalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NRC Relative Value
Base Case
23.44 USD
Undervaluation 23%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.9
P/S
P/S
Price to Sales
2.9
vs History
79
vs Industry
43
Median 3Y
4.5
Median 5Y
6.2
Industry
2.3
More Details
24.9
P/E
P/E
Price to Earnings
24.9
vs History
60
vs Industry
36
Median 3Y
24.1
Median 5Y
26.8
Industry
22.4
More Details
15.9
P/OCF
P/OCF
Price to OCF
15.9
vs History
71
vs Industry
39
Median 3Y
18.1
Median 5Y
21.8
Industry
14.4
More Details
11.6
P/FCFE
P/FCFE
Price to FCFE
11.6
vs History
74
vs Industry
38
Median 3Y
14.4
Median 5Y
27.9
Industry
21.5
More Details
28.5
P/B
P/B
Price to Book Value
28.5
vs History
0
vs Industry
6
Median 3Y
14
Median 5Y
13.9
Industry
2.2
More Details
3.5
EV/S
EV/S
Enterprise Value to Sales
3.5
vs History
77
vs Industry
40
Median 3Y
4.7
Median 5Y
6.1
Industry
2.5
More Details
5.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.6
vs History
77
vs Industry
47
Median 3Y
7.5
Median 5Y
9.7
Industry
5.1
More Details
13.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.2
vs History
71
vs Industry
36
Median 3Y
14.3
Median 5Y
16.3
Industry
12
More Details
16.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.3
vs History
66
vs Industry
38
Median 3Y
16.4
Median 5Y
17.9
Industry
17.1
More Details
18.8
EV/OCF
EV/OCF
Enterprise Value to OCF
18.8
vs History
71
vs Industry
37
Median 3Y
20
Median 5Y
22.2
Industry
14.7
More Details
41.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
41.4
vs History
17
vs Industry
28
Median 3Y
37.2
Median 5Y
28.7
Industry
18.8
More Details
3.8
EV/IC
EV/IC
Enterprise Value to IC
3.8
vs History
77
vs Industry
26
Median 3Y
5.9
Median 5Y
8.7
Industry
1.8
More Details

Multiples Across Competitors

NRC Competitors Multiples
National Research Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
National Research Corp
NASDAQ:NRC
407.8m USD 2.9 24.9 13.2 16.3
US
CVS Health Corp
NYSE:CVS
101.2B USD 0.3 215.8 14.1 14.1
US
Cigna Corp
NYSE:CI
73.9B USD 0.3 12 7.7 9.8
US
Cigna Group
XMUN:CGN
62.2B EUR 0.3 11.9 7.7 9.8
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.3B EUR 1.2 23.9 10.4 15.9
DE
Fresenius Medical Care AG
XMUN:FME
23.6B EUR 1.2 32.9 10.4 22.1
US
Laboratory Corporation of America Holdings
NYSE:LH
21.9B USD 1.6 25.6 13.8 19.3
US
Quest Diagnostics Inc
NYSE:DGX
20.4B USD 1.9 21.2 11.7 15.8
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.6B EUR 0.6 16.2 6.4 13.6
US
Guardant Health Inc
NASDAQ:GH
12.8B USD 14.2 -32.2 -34 -30.8
US
DaVita Inc
NYSE:DVA
8.5B USD 0.6 11 6.8 9.3

See Also

Summary
NRC intrinsic value, competitors valuation, and company profile.
DCF Valuation
NRC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NRC stock valuation using valuation multiples.
Wall Street Estimates
NRC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NRC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.